Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer SPF 50, Zinc Oxide 21%, 2.1 oz/61 g per tube, Manufactured by CA BOTANA, San Diego, CA 92121. NDC: 35192-043-17
CA BOTANA International
💊 Drugs Class I - Dangerous
CGMP Deviations
All Recalls
95,064 total recalls in our database
Gabriel Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz, Net 61 g per tube, Dist. By: Gabriel Cosmetics, Inc., Redmond, WA USA 98052, NDC: 35192-044-01, UPC 7 07060 9592 1
CA BOTANA International
💊 Drugs Class I - Dangerous
CGMP Deviations
Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, NDC 0363-3114-01
Medical Products Laboratories
💊 Drugs Class I - Dangerous
Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
Dr. Bump Natural Pain Relief Gel, Menthol 5%, NET WT 4 FL OZ/118 ML per bottle, Distr. by 1Beauty US LLC, Palm Desert, CA 92211. NDC: 35192-052-18, UPC 8 18204 02513 8
CA BOTANA International
💊 Drugs Class I - Dangerous
CGMP Deviations
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Due to Users not having access to the Instructions for Use/User Manual due to it being password protected.
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
FoundationOne CDx (F1CDx), RAL-0003 version 31.0
Foundation Medicine
🏥 Medical Devices Class I - Dangerous
Reports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence.
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
🏥 Medical Devices Class I - Dangerous
Product testing did not meet expected stability criteria.
🏥 Medical Devices Class I - Dangerous
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).